Digitisation | August 08, 2025
ekincare launches elva.AI to resolve 80% of employee healthcare queries
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
ekincare has raised a total funding of $22M since 2015 till date
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
Based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more than one year
Around 7% of the Indian population suffers from IBS
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
Subscribe To Our Newsletter & Stay Updated
